Ryan F. Quarles: “If there is a credit allocation decision to be made, that is a decision for Congress, to be debated by the public's…”

I think that you can actually have more effect in really supporting the low- and moderate-income portions of the communities.

I do think that a legislature is in a better position to resist the slippery slope for that solution.

That is probably the highest priority item that we have, discussing ways to ensure that our systems are resilient.

The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.